GlaxoSmithKline (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

1,295.00p
   
  • Change Today:
      4.50p
  • 52 Week High: 1,722.00
  • 52 Week Low: 1,275.50
  • Currency: UK Pounds
  • Shares Issued: 4,918.69m
  • Volume: 15,049,865
  • Market Cap: 63,697m
  • RiskGrade: 92

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 6.2% 6.2%
Div Cover 1.3 1.4
Op Mrgn 9.3% 25.9%
ROCE 162.9%  
Latest F'cast
P/E 12.6 11.7
PEG 0.4 1.5
Pr/Revenue 2.3 2.1
Pr/Book 12.8  
Latest F'cast
Revenue 16.6% 7.9%
PBT -81.6% 301.9%
EPS 35.3% 7.8%
DPS n/a 0.0%

GlaxoSmithKline Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 26,431.00 6,600.00 111.40p 12.0 n/a -2% 74.00p 5.5%
31-Dec-13 26,505.00 6,647.00 108.40p 14.9 n/a -3% 78.00p 4.8%
31-Dec-14 23,006.00 2,968.00 95.40p 14.4 n/a -12% 80.00p 5.8%
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 30,088.75 7,793.10 110.43p 11.7 1.5 +8% 80.00p 6.2%
31-Dec-18 30,496.31 7,770.39 107.59p 12.0 n/a -3% 80.01p 6.2%

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.

GlaxoSmithKline Company Announcements

Transfer of Shares out of Treasury 15-Dec-2017 07:00 RNS
Director/PDMR Shareholding 12-Dec-2017 16:50 RNS
GSK gains US approval for Nucala to treat EGPA 12-Dec-2017 16:16 RNS

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
11-Dec-17 Transfer From Emma Walmsley 0.000p 9 0.00
11-Dec-17 Transfer From Simon Dingemans 0.000p 9 0.00
11-Dec-17 Transfer From Victoria Whyte 0.000p 9 0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,295.00p
Change Today 4.50p
% Change 0.35 %
52 Week High 1,722.00
52 Week Low 1,275.50
Volume 15,049,865
Shares Issued 4,918.69m
Market Cap 63,697m
RiskGrade 92

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
10.04% above the market average10.04% above the market average10.04% above the market average10.04% above the market average10.04% above the market average
83.87% above the sector average83.87% above the sector average83.87% above the sector average83.87% above the sector average83.87% above the sector average
Price Trend
64.07% below the market average64.07% below the market average64.07% below the market average64.07% below the market average64.07% below the market average
23.08% below the sector average23.08% below the sector average23.08% below the sector average23.08% below the sector average23.08% below the sector average
Income
90.44% above the market average90.44% above the market average90.44% above the market average90.44% above the market average90.44% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
7.62% above the market average7.62% above the market average7.62% above the market average7.62% above the market average7.62% above the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average

What The Brokers Say

Strong Buy 12
Buy 0
Neutral 17
Sell 0
Strong Sell 4
Total 33
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q3 Q2
Ex-Div 09-Nov-17 10-Aug-17
Paid 11-Jan-18 12-Oct-17
Amount 19.00p 19.00p

Trades for 15-Dec-2017

Time Volume / Share Price
17:04 11,840 @ 1,296.41p
17:03 400,000 @ 1,295.71p
16:53 671 @ 1,292.37p
16:53 26 @ 1,292.39p
16:50 12,300 @ 1,295.00p

GlaxoSmithKline Key Personnel

CFO Simon Dingemans
CEO Emma Walmsley

Top of Page